NYSE · Health Care

CARDINAL HEALTH INC CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Other Pharmaceuticals

Company profile

Business mix

  • It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
  • The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
  • It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
  • The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical distribution?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 2 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 31.47 FCF 9.1% Buyback 2.36%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Gotham Asset Management Joel Greenblatt 0.1% $37.4M 2026-03-31
Bridgewater Associates Ray Dalio 0.1% $24.3M 2026-03-31

Recent trading changes over the last 4 quarters

Net buyers 3 Last 4 13F filing periods
Net reducers 0 Last 4 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $40.1M Estimated from net added shares
Reduction amount $0 Estimated from net reduced shares
Net share change / base shares +173.1% +192,091 / 110,978
Bridgewater Associates Ray Dalio 4 filing periods
13F 2025-06-30 Filed 2025-08-13
Major increase Shares 258.0% 13F value change +$33.5M
13F 2025-09-30 Filed 2025-11-13
Minor increase Shares 5.1% 13F value change -$772,540
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -20.4% 13F value change +$1.8M
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -46.8% 13F value change -$20.2M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 72,283 Last 4 periods +42,946 (+59.4%) Total shares 115,229 Value $24.3M
Gotham Asset Management Joel Greenblatt 4 filing periods
13F 2025-06-30 Filed 2025-08-14
Major increase Shares 189.3% 13F value change +$13.5M
13F 2025-09-30 Filed 2025-11-14
Major increase Shares 18.8% 13F value change +$2.1M
13F 2025-12-31 Filed 2026-02-17
Major increase Shares 25.0% 13F value change +$13.3M
13F 2026-03-31 Filed 2026-05-15
Minor increase Shares 6.6% 13F value change +$3.3M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 38,695 Last 4 periods +138,501 (+357.9%) Total shares 177,196 Value $37.4M
Southeastern Asset Management Mason Hawkins 2 filing periods
13F 2025-03-31 Filed 2025-05-15
New Shares - 13F value change +$2.4M
13F 2025-06-30 Filed 2025-08-14
Major reduction Shares -39.5% 13F value change -$633,943
Settlement As of 13F 2025-06-30 · Filed 2025-08-14
Base shares 0 Last 4 periods +10,644 (New) Total shares 10,644 Value $1.8M

Recent mentions

No public mentions.